June 12, 2013 Bioniche Founder and CEO Addresses Shareholders
June 5, 2013 Paladin Labs Inc. and Bioniche Life Sciences Inc. Sign Debt Refinancing and Urocidin™ Licensing Deals
Latest TSX stock price
All prices delayed at least 15 minutes.Source: TSX Inc.
Latest ASX stock price
All prices delayed at least 20 minutes.Source: ASX Inc.
Inquiries related to stock transfer, lost certificates or address changes should be directed to our Transfer Agent, CIBC Mellon Trust Company.
CIBC Mellon Trust Company c/o Canadian Stock Transfer Company Inc. P.O. Box 700, Station B Montreal, QC, H3B 3K3 Tel: 1 (800) 387-0825 / (416) 682-3860 Fax: 1 (888) 249-6189 E-mail: inquiries@canstockta.com Website: www.canstockta.com
Bioniche financial reports can be downloaded here
Request investor materials by regular mail here
All Bioniche publicly-listed documents can be viewed here
To automatically receive an e-mail alert when Bioniche news releases are posted to this site, enter your e-mail address here.
Copyright 2004, Bioniche Life Sciences Inc. All rights reserved | Legal Disclaimer | Privacy Policy